American Bio Medica wins legal round in patent dispute
This article was originally published in Clinica
Executive Summary
American Bio Medica has won the latest round in its patent litigation with Phamatech concerning urine-based drug-of-abuse testing kits in the US. The Delaware district court has denied Phamatech's request to throw out American Bio Medica's patent infringement case against Phamatech and other defendants. The trial has also been moved to California, the home state of Phamatech.